phenylalanine has been researched along with sq-11725 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avdeef, A; Tam, KY | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Abu-Reish, IA; Aljada, A; Bapna, V; Dandona, P; Ghanim, H; Hamouda, W; Magsino, CH | 1 |
1 trial(s) available for phenylalanine and sq-11725
Article | Year |
---|---|
Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Chromatography, High Pressure Liquid; Female; Humans; Leukocytes, Mononuclear; Linoleic Acid; Male; Nadolol; Neutrophils; Oxidation-Reduction; Phenylalanine; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Tyrosine | 2000 |
2 other study(ies) available for phenylalanine and sq-11725
Article | Year |
---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |